T1	Participants 88 116	patients with gastric ulcer.
T2	Participants 151 185	Patients with benign gastric ulcer
T3	Participants 381 441	Fifty two patients entered the trial, and 12 were withdrawn.
T4	Participants 1178 1191	peptic ulcer.
